Skip to main content
. 2024 Mar 5;8(4):102133. doi: 10.1016/j.cdnut.2024.102133

TABLE 1.

Participant characteristics

Total Total fish intake
Q1 Q2 Q3 Q4
Participants, n 1545 387 386 386 386
Total fish (g/1000 kcal) [median (min–max)] 14 (0–19.7) 24 (19.8–29.4) 36 (29.5–44.6) 58 (44.9–162.9)
Age (y) 63.5 (3.5) 63.5 (3.5) 63.3 (3.5) 63.4 (3.4) 63.9 (3.5)
Marital status, married 90.6 90.8 91.1 88.7 91.6
Education, <10 y 5.0 4.9 4.4 2.6 8.0
Employment status, employed 71.4 73.0 71.1 70.8 70.7
Household income, <3 million Japanese yen/y 30.3 29.1 27.2 33.9 30.9
Current use of cholesterol/triglyceride-lowering medication 23.4 25.8 20.9 23.1 24.0
Comorbidities
 Diabetes1 23.2 24.4 22.0 21.4 25.1
 Hypertension2 48.2 47.0 47.7 48.2 50.0
 Dyslipidemia3 59.0 63.8 58.8 59.1 54.4
 Cancer 6.6 5.7 8.0 7.8 4.9
 Chronic kidney disease 1.3 1.6 1.6 0.8 1.3
 Cardiovascular disease 11.8 12.4 10.6 12.2 12.2
BMI (kg/m2) 24.2 (3.1) 24.4 (3.0) 23.9 (2.9) 24.4 (3.5) 24.1 (3.1)
Smoking status, current 22.1 22.7 23.6 23.1 19.2
Sleep duration, <7 h/d 37.4 40.3 39.5 36.1 33.6
Physical activity on leisure, ≥10 METs h/wk 35.0 34.2 34.8 35.6 35.5
Dietary intake (/d)
 Total energy (kcal) 1957 (554) 1821 (554) 1942 (506) 2005 (552) 2060 (574)
 Alcohol (g) [median (IQR)] 12.1 (1.0–30.1) 10.2 (0.2–30.1) 12.0 (1.0–28.7) 14.3 (1.2–33.4) 11.9 (1.2–28.6)
 Protein (% energy) 14.8 (2.9) 12.7 (2.3) 13.8 (2.0) 15.0 (1.9) 17.8 (2.6)
 Cholesterol (mg/1000 kcal) 195.3 (74.0) 167.3 (79.7) 180.8 (62.7) 192.3 (60.0) 240.8 (70.6)
 n-3 PUFAs (g/1000 kcal) 1.4 (0.5) 1.0 (0.3) 1.2 (0.3) 1.5 (0.3) 1.9 (0.4)
 Vitamin D (μg/1000 kcal) 7.2 (4.4) 3.2 (1.1) 5.3 (0.9) 7.6 (1.3) 13.0 (4.3)
 Zinc (mg/1000 kcal) 4.3 (0.7) 4.1 (0.7) 4.2 (0.6) 4.3 (0.6) 4.7 (0.6)
 Magnesium (mg/1000 kcal) 136.7 (28.2) 124.3 (26.4) 129.6 (25.8) 138.1 (22.4) 154.7 (28.1)

Data are presented as percentages or mean (standard deviation) except where noted.

Abbreviations: BMI, body mass index; IQR, inter quartile range; HbA1c, hemoglobin A1c; MET, metabolic equivalent; Q, quartile.

1

Defined as fasting plasma glucose ≥126 mg/dL, HbA1c ≥6.5%, and/or self-reported medical history or medication use for diabetes.

2

Defined as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, and/or self-reported medical history or medication use for hypertension.

3

Defined as low-density lipoprotein-cholesterol ≥140 mg/dL, triglyceride ≥150 mg/dL, high-density lipoprotein-cholesterol <40 mg/dL, and/or self-reported medical history or medication use for dyslipidemia.